Daly James M
CIK 0001560782 Name as filed on the most recent filing
Filed as Daly James M (23)
47 transaction lines · from 23 filings · filed 2014-02-18 to 2025-11-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Acadia Pharmaceuticals Inc 3 filings
- ISSUER Madrigal Pharmaceuticals, Inc. 2 filings
- ISSUER Halozyme Therapeutics, Inc. 3 filings
- ISSUER Incyte Corp 15 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
47 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-11-10 |
Acadia Pharmaceuticals Inc ACAD |
S, Open-market sale | 30,000 disposed | 22.37 | 670,983.00 | Form 4, filing 0001560782-25-000006 | |
| 2025-02-27 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 14,302 disposed | 347.39 | 4,968,371.78 | Form 4, filing 0001628280-25-009079 | |
| 2025-02-27 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 770 disposed | 348.94 | 268,686.34 | Form 4, filing 0001628280-25-009079 | |
| 2025-02-27 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 398 disposed | 346.90 | 138,067.43 | Form 4, filing 0001628280-25-009079 | |
| 2024-04-02 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 6,279 disposed | 244.19 | 1,533,285.96 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-02 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 2,991 disposed | 244.89 | 732,479.75 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-02 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 842 disposed | 243.26 | 204,821.47 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-02 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 557 disposed | 246.30 | 137,186.76 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-02 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 200 disposed | 248.45 | 49,690.16 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-02 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 43 disposed | 247.03 | 10,622.47 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 7,401 disposed | 256.50 | 1,898,370.56 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 6,809 disposed | 255.64 | 1,740,629.61 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 3,604 disposed | 257.30 | 927,302.35 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 1,460 disposed | 258.28 | 377,093.76 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 800 disposed | 262.00 | 209,604.00 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 500 disposed | 265.49 | 132,743.00 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 351 disposed | 264.89 | 92,976.67 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 274 disposed | 266.91 | 73,132.02 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 200 disposed | 259.11 | 51,822.00 | Form 4, filing 0000899243-24-000243 | |
| 2024-04-01 |
Madrigal Pharmaceuticals, Inc. MDGL |
S, Open-market sale | 178 disposed | 263.31 | 46,869.77 | Form 4, filing 0000899243-24-000243 | |
| 2023-08-14 |
Halozyme Therapeutics, Inc. HALO |
S, Open-market sale | 10,000 disposed | 43.74 | 437,410.00 | Form 4, filing 0001415889-23-012257 | |
| 2023-08-11 |
Halozyme Therapeutics, Inc. HALO |
S, Open-market sale | 10,000 disposed | 43.71 | 437,110.00 | Form 4, filing 0001415889-23-012257 | |
| 2020-11-25 |
Halozyme Therapeutics, Inc. HALO |
S, Open-market sale | 10,363 disposed | 40.41 | 418,799.92 | Form 4, filing 0001179110-20-011427 | |
| 2020-08-13 |
Halozyme Therapeutics, Inc. HALO |
S, Open-market sale | 34,337 disposed | 29.12 | 999,893.44 | Form 4, filing 0001179110-20-009018 | |
| 2020-05-11 |
Acadia Pharmaceuticals Inc ACAD |
S, Open-market sale | 26,250 disposed | 51.13 | 1,342,178.25 | Form 4, filing 0001209191-20-028940 | |
| 2019-09-09 |
Acadia Pharmaceuticals Inc ACAD |
S, Open-market sale | 29,600 disposed | 37.79 | 1,118,504.08 | Form 4, filing 0001209191-19-049230 | |
| 2019-09-09 |
Acadia Pharmaceuticals Inc ACAD |
S, Open-market sale | 400 disposed | 38.39 | 15,356.00 | Form 4, filing 0001209191-19-049230 | |
| 2015-06-23 |
Incyte Corp INCY |
S, Open-market sale | 10,710 disposed | 108.28 | 1,159,678.80 | Form 4, filing 0001209191-15-056296 | |
| 2015-06-23 |
Incyte Corp INCY |
S, Open-market sale | 981 disposed | 107.84 | 105,791.04 | Form 4, filing 0001209191-15-056296 | |
| 2015-05-26 |
Incyte Corp INCY |
S, Open-market sale | 11,112 disposed | 106.43 | 1,182,650.16 | Form 4, filing 0001209191-15-047528 | |
| 2015-05-26 |
Incyte Corp INCY |
S, Open-market sale | 981 disposed | 106.00 | 103,986.00 | Form 4, filing 0001209191-15-047528 | |
| 2015-04-23 |
Incyte Corp INCY |
S, Open-market sale | 22,223 disposed | 107.67 | 2,392,750.41 | Form 4, filing 0001209191-15-036093 | |
| 2015-04-23 |
Incyte Corp INCY |
S, Open-market sale | 14,718 disposed | 107.67 | 1,584,687.06 | Form 4, filing 0001209191-15-036093 | |
| 2015-02-24 |
Incyte Corp INCY |
S, Open-market sale | 8,334 disposed | 81.77 | 681,471.18 | Form 4, filing 0001209191-15-018691 | |
| 2015-02-23 |
Incyte Corp INCY |
S, Open-market sale | 2,778 disposed | 83.44 | 231,796.32 | Form 4, filing 0001209191-15-018691 | |
| 2015-01-23 |
Incyte Corp INCY |
S, Open-market sale | 11,109 disposed | 77.68 | 862,947.12 | Form 4, filing 0001209191-15-006536 | |
| 2014-12-23 |
Incyte Corp INCY |
S, Open-market sale | 11,113 disposed | 74.43 | 827,140.59 | Form 4, filing 0001181431-14-039732 | |
| 2014-11-24 |
Incyte Corp INCY |
S, Open-market sale | 11,111 disposed | 74.08 | 823,102.88 | Form 4, filing 0001181431-14-037404 | |
| 2014-10-23 |
Incyte Corp INCY |
S, Open-market sale | 11,111 disposed | 53.49 | 594,327.39 | Form 4, filing 0001181431-14-034802 | |
| 2014-09-23 |
Incyte Corp INCY |
S, Open-market sale | 11,111 disposed | 47.65 | 529,439.15 | Form 4, filing 0001181431-14-032614 | |
| 2014-08-25 |
Incyte Corp INCY |
S, Open-market sale | 11,111 disposed | 51.96 | 577,327.56 | Form 4, filing 0001181431-14-030292 | |
| 2014-07-23 |
Incyte Corp INCY |
S, Open-market sale | 11,111 disposed | 48.54 | 539,327.94 | Form 4, filing 0001181431-14-027420 | |
| 2014-06-23 |
Incyte Corp INCY |
S, Open-market sale | 8,334 disposed | 55.92 | 466,037.28 | Form 4, filing 0001181431-14-024975 | |
| 2014-06-23 |
Incyte Corp INCY |
S, Open-market sale | 2,777 disposed | 56.38 | 156,567.26 | Form 4, filing 0001181431-14-024975 | |
| 2014-05-23 |
Incyte Corp INCY |
S, Open-market sale | 11,111 disposed | 48.48 | 538,661.28 | Form 4, filing 0001181431-14-021465 | |
| 2014-04-23 |
Incyte Corp INCY |
S, Open-market sale | 30,555 disposed | 47.71 | 1,457,779.05 | Form 4, filing 0001181431-14-016910 | |
| 2014-02-13 |
Incyte Corp INCY |
S, Open-market sale | 158,331 disposed | 66.49 | 10,527,428.19 | Form 4, filing 0001181431-14-007428 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 47
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Daly James M, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001560782
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6